How to make accessible for practice new diagnostic approaches created by science
09.00 HOW TO MAKE ACCESSIBLE FOR PRACTICE NEW DIAGNOSTIC APPROACHES CREATED BY SCIENCE
Seminars with WHO EXPERTS Chairman: Dr Yana I. Gurkovskaya & Dr Farkhad Shamilov, Petrovax
09.00 Influence of polyoxidonium (immune adjuvant) on primary tumor and bone marrow in breast cancer patients. Chairman: Dr Maria.E. Ilatovskaya09.30 Perspectives of CTC and DTC HER2 detection for therapeutic targeting: questions and concerns.
10.00 Coffee break
Chairman: Prof Nikolay N.Tupitsyn, Moscow, Russia & Lubov Kuprova, Bioline10.30 8-color Euroflow panels in MRD diagnosis in leukemias and lymphomas. Chairmen: Prof Piarvin A. Zeynalova, Prof Timur T. Valiev & Mobil Akhmedov
11.30 YOUNG SCIENTIST SELECTED ORAL PRESENTATIONS11.30 Antigen expression heterogenicity used for MRD monitoring in B-lymphoblastic leukemia. Kateryna Vilchevska, Donetsk, Ukraine
11.50 Hospicell, a subset of bone marrow stromal cell regulate ATP-binding cassette gene expression via insulin-like growth factor-I in a leukemia cell line. Nadia Benabou, Paris, France12.00 Role of telomerase mutation on myelodysplastic syndrome and other haematopoietic disorders. Sushama Jose Shyam, Brno, Czech Republic
12.10 Take home message.